Pharmx Technologies Ltd (PHX) — Capital Reinvestment Ratio

Latest as of June 2024: 0.49x

Pharmx Technologies Ltd (PHX) has a Capital Reinvestment Ratio of 0.49x as of June 2024, meaning it reinvests 0% of its operating cash flow (AU$3.21 Million) in capital expenditures (AU$1.58 Million). See free cash flow generation of Pharmx Technologies Ltd to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.49x
Capex / Operating Cash Flow

Operating Cash Flow

AU$3.21 Million
AUD

Capital Expenditures

AU$1.58 Million
AUD

Data as of

Jun 2024
Most recent filing

Pharmx Technologies Ltd Capital Reinvestment Ratio (2007–2024)

This chart tracks Pharmx Technologies Ltd's Capital Reinvestment Ratio across 16 annual periods.

Annual Capital Reinvestment Ratio for Pharmx Technologies Ltd (2007–2024)

Year-by-year Capital Reinvestment Ratio for Pharmx Technologies Ltd from 2007 to 2024. For live market cap and broader valuation context, see PHX stock market capitalisation.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2024 0.49x AU$3.21 Million AU$1.58 Million ▲ +60.8%
2023 0.31x AU$10.94 Million AU$3.36 Million ▼ -83.1%
2022 1.81x AU$2.19 Million AU$3.98 Million ▲ +40.2%
2021 1.29x AU$3.16 Million AU$4.09 Million ▼ -85.5%
2020 8.90x AU$369.00K AU$3.28 Million ▲ +251.6%
2019 2.53x AU$1.35 Million AU$3.41 Million ▼ -75.7%
2018 10.42x AU$332.00K AU$3.46 Million ▲ +23.4%
2017 8.44x AU$249.00K AU$2.10 Million ▲ +11550.3%
2015 0.07x AU$3.53 Million AU$256.00K ▲ +661.8%
2014 0.01x AU$5.68 Million AU$54.00K ▲ +124.6%
2013 0.00x AU$6.61 Million AU$28.00K ▼ -90.6%
2012 0.04x AU$4.67 Million AU$210.00K ▲ +6.7%
2011 0.04x AU$3.67 Million AU$155.00K ▼ -89.3%
2010 0.39x AU$2.26 Million AU$890.00K ▼ -44.1%
2008 0.70x AU$4.46 Million AU$3.14 Million ▼ -24.6%
2007 0.93x AU$2.65 Million AU$2.47 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow